These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7008255)

  • 21. HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
    Thole JE; Janson AA; Cornelisse Y; Schreuder GM; Wieles B; Naafs B; de Vries RR; Ottenhoff TH
    J Immunol; 1999 Jun; 162(11):6912-8. PubMed ID: 10352313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells.
    Mitra DK; Rajalingam R; Taneja V; Bhattacharyya BC; Mehra NK
    Clin Immunol Immunopathol; 1997 Jan; 82(1):60-7. PubMed ID: 9000043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of the HLA class II frequency alleles in patients with leprosy from the mid-west of Brazil.
    Lavado-Valenzuela R; José Bravo M; Junqueira-Kipnis AP; Ramos de Souza M; Moreno C; Alonso A; Liberman-Kipnis T; da Silva WD; Caballero A
    Int J Immunogenet; 2011 Jun; 38(3):255-8. PubMed ID: 21599852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
    Nath I; Van Rood JJ; Mehra NK; Vaidya MC
    Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occasional review--HLA and leprosy: a re-evaluation.
    van Eden W; de Vries RR
    Lepr Rev; 1984 Jun; 55(2):89-104. PubMed ID: 6431213
    [No Abstract]   [Full Text] [Related]  

  • 27. Associations between human leukocyte antigens and leprosy in the Turkish population.
    Koçak M; Balci M; Pençe B; Kundakçi N
    Clin Exp Dermatol; 2002 May; 27(3):235-9. PubMed ID: 12072016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population.
    Ottenhoff TH; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
    Tissue Antigens; 1984 Jul; 24(1):25-9. PubMed ID: 6592792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leprosy and immunity: genetics and immune function in multiple case families.
    Rawlinson WD; Basten A; Britton WJ; Serjeantson SW
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():9-21. PubMed ID: 3286485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+ T-cell responses to recombinant hsp65 and hsp18 of M. leprae and their trypsin-digested fragments in leprosy: diversity in HLA-DR restriction.
    Mitra DK; Mehra NK; Maiti TK; Banerjee A; Taneja V; Rajalingam R; Ahuja RK; Bhattacharya BC
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):518-28. PubMed ID: 8642214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-linked control of predisposition to lepromatous leprosy.
    Xu KY; de Vries RR; Fei HM; van Leeuwen A; Chen RB; Ye GY
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):56-63. PubMed ID: 3858394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.
    Collings LA; Tidman N; Poulter LW
    Clin Exp Immunol; 1985 Jul; 61(1):58-66. PubMed ID: 3862470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA antigens and neural reversal reactions in Ethiopian borderline tuberculoid leprosy patients.
    Ottenhoff TH; Converse PJ; Bjune G; de Vries RR
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):261-6. PubMed ID: 3474306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The genetic susceptibility to leprosy in humans].
    Lagrange PH; Abel L
    Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class-II immune response genes and products in leprosy.
    de Vries RR; van Eden W; Ottenhoff TH
    Prog Allergy; 1985; 36():95-113. PubMed ID: 3918314
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria.
    Haanen JB; Ottenhoff TH; Lai A Fat RF; Soebono H; Spits H; de Vries RR
    J Immunol; 1990 Dec; 145(11):3898-904. PubMed ID: 1701000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.